Irwin D. Walker
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Chimerism practices across Canadian transplant centres: review of current standards and variations.
Journal: Frontiers in transplantation
Published: May 12, 2026
Correction: Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study.
Journal: Blood cancer journal
Published: March 02, 2026
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium.
Journal: Bone marrow transplantation
Published: February 23, 2026
Impact of Modern Strategies for Graft-Versus-Host Disease Prophylaxis on Relapse Risk in Matched-Sibling or Unrelated Donor Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis of Randomized Trials.
Journal: European journal of haematology
Published: February 04, 2026
Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia.
Journal: Leukemia & lymphoma
Published: November 06, 2025
Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma.
Journal: Current oncology (Toronto, Ont.)
Published: January 16, 2025
Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: JACC. Advances
Published: December 23, 2024
Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.
Journal: Transplantation and cellular therapy
Published: July 18, 2024
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
Journal: Current oncology (Toronto, Ont.)
Published: January 14, 2024
Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 30, 2023
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 17, 2021
Last Updated: 09/26/2026